Cdx2 homeoprotein inhibits non-homologous end joining in colon cancer but not in leukemia cells

Nucleic Acids Research

Volumn 40, Issue 8, 2012, Pages 3456-3469

  Renouf, Benjamin ^a,b   Soret, Christine ^a,b   Saandi, Thoueiba ^a,b   Delalande, Franois ^b,c   Martin, Elisabeth ^a,b   Vanier, Marie ^a,b   Duluc, Isabelle ^a,b   Gross, Isabelle ^a,b   Freund, Jean Noël ^a,b   Domon Dell, Claire ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

^c INSTITUT DE RECHERCHES SUBATOMIQUES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; DNA DEPENDENT PROTEIN KINASE; DNA DEPENDENT PROTEIN KINASE LARGE CATALYTIC SUBUNIT; DOXYCYCLINE; ETOPOSIDE; HETERODIMER; HISTONE H2AX; KU ANTIGEN; PROTEIN KU80; TRANSCRIPTION FACTOR CDX2; UNCLASSIFIED DRUG;

ALPHA HELIX; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CDX2 GENE; CELL SPECIFICITY; CELL SURVIVAL; COLON CANCER; COMPLEX FORMATION; CONTROLLED STUDY; DNA END JOINING REPAIR; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GENOTOXICITY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTESTINE CELL; LEUKEMIA CELL; METABOLIC INHIBITION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; TANDEM AFFINITY PURIFICATION; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

ANTIGENS, NUCLEAR; CELL LINE, TUMOR; CELL SURVIVAL; COLONIC NEOPLASMS; DNA END-JOINING REPAIR; DNA-ACTIVATED PROTEIN KINASE; DNA-BINDING PROTEINS; ETOPOSIDE; HOMEODOMAIN PROTEINS; HUMANS; LEUKEMIA; PROTEIN INTERACTION DOMAINS AND MOTIFS; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEINS;

EID: 84860358349     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkr1242     Document Type: Article

References (45)

1. Chawengsaksophak, K., James, R., Hammond, V.E., Kontgen, F. and Beck, F. (1997) Homeosis and intestinal tumours in Cdx2 mutant mice. Nature, 386, 84-87.
2. Chawengsaksophak, K., De Graaff, W., Rossant, J., Deschamps, J. and Beck, F. (2004) Cdx2 is essential for axial elongation in mouse development. Proc. Natl Acad. Sci. USA, 101, 7641-7645.
3. Van Den Akker, E., Forlani, S., Chawengsaksophak, K., De Graaff, W., Beck, F., Meyer, B.I. and Deschamps, J. (2002) Cdx1 and Cdx2 have overlapping functions in anteroposterior patterning and posterior axis elongation. Development, 129, 2181-2193.
4. Beck, F., Chawengsaksophak, K., Waring, P., Playford, R.J. and Furness, J.B. (1999) Reprogramming of intestinal differentiation and intercalary regeneration in Cdx2 mutant mice. Proc. Natl Acad. Sci. USA, 96, 7318-7323.
5. Gao, N., White, P. and Kaestner, K.H. (2009) Establishment of intestinal identity and epithelial-mesenchymal signaling by Cdx2. Dev. Cell, 16, 588-599.
6. Crissey, M.A., Guo, R., Funakoshi, S., Kong, J., Liu, J. and Lynch, J.P. (2011) Cdx2 levels modulate intestinal epithelium maturity and paneth cell development. Gastroenterology, 140, 517-528.
7. Verzi, M.P., Shin, H., He, H.H., Sulahian, R., Meyer, C.A., Montgomery, R.K., Fleet, J.C., Brown, M., Liu, X.S. and Shivdasani, R.A. (2010) Differentiation-specific histone modifications reveal dynamic chromatin interactions and partners for the intestinal transcription factor CDX2. Dev. Cell., 19, 713-726.
8. Calon, A., Gross, I., Lhermitte, B., Martin, E., Beck, F., Duclos, B., Kedinger, M., Duluc, I., Domon-Dell, C. and Freund, J.N. (2007) Different effects of the Cdx1 and Cdx2 homeobox genes in a murine model of intestinal inflammation. Gut, 56, 1688-1695.
9. Kim, S.P., Park, J.W., Lee, S.H., Lim, J.H., Jang, B.C., Lee, S.H., Jang, I.H., Freund, J.N., Suh, S.I., Mun, K.C. et al. (2004) Homeodomain protein CDX2 regulates COX-2 expression in colorectal cancer. Biochem. Biophys. Res. Commun., 315, 93-99.
10. Mutoh, H., Hayakawa, H., Sakamoto, H. and Sugano, K. (2007) Homeobox protein CDX2 reduces Cox-2 transcription by inactivating the DNA-binding capacity of nuclear factor-kB. J. Gastroenterol., 42, 719-729.
11. Guo, R.J., Funakoshi, S., Lee, H.H., Kong, J. and Lynch, J.P. (2010) The intestine-specific transcription factor Cdx2 inhibits beta-catenin/TCF transcriptional activity by disrupting the beta-catenin-TCF protein complex. Carcinogenesis, 31, 159-166.
12. Aoki, K., Kakizaki, F., Sakashita, H., Manabe, T., Aoki, M. and Taketo, M.M. (2011) Suppression of colonic polyposis by homeoprotein CDX2 through its nontranscriptional function that stabilizes p27Kip1. Cancer Res., 71, 593-602.
13. Aoki, K., Tamai, Y., Horiike, S., Oshima, M. and Taketo, M.M. (2003) Colonic polyposis caused by Mtor-mediated chromosomal instability in Apc +delta;716 Cdx2 +-compound mutant mice. Nat. Genet., 35, 323-330.
14. Bonhomme, C., Duluc, I., Martin, E., Chawengsaksophak, K., Chenard, M.P., Kedinger, M., Beck, F., Freund, J.N. and Domon-Dell, C. (2003) The Cdx2 homeobox gene has a tumour suppressor function in the distal colon in addition to a homeotic role during gut development. Gut, 52, 1465-1471.
15. Gross, I., Duluc, I., Benameur, T., Calon, A., Martin, E., Brabletz, T., Kedinger, M., Domon-Dell, C. and Freund, J.N. (2008) The intestine-specific homeobox gene Cdx2 decreases mobility and antagonizes dissemination of colon cancer cells. Oncogene, 27, 107-115.
16. Scholl, C., Bansal, D., Dohner, K., Eiwen, K., Huntly, B.J., Lee, B.H., Rucker, F.G., Schlenk, R.F., Bullinger, L., Dohner, H. et al. (2007) The homeobox gene CDX2 is aberrantly expressed in most cases of acute myeloid leukemia and promotes leukemogenesis. J. Clin. Invest., 117, 1037-1048.
17. Thoene, S., Rawat, V.P., Heilmeier, B., Hoster, E., Metzeler, K.H., Herold, T., Hiddemann, W., Gokbuget, N., Hoelzer, D., Bohlander, S.K. et al. (2009) The homeobox gene CDX2 is aberrantly expressed and associated with an inferior prognosis in patients with acute lymphoblastic leukemia. Leukemia, 23, 649-655.
18. Rothkamm, K. and Lobrich, M. (2002) Misrepair of radiation-induced DNA double-strand breaks and its relevance for tumorigenesis and cancer treatment (Review). Int J Oncol., 21, 433-440.
19. Delacote, F. and Lopez, B.S. (2008) Importance of the cell cycle phase for the choice of the appropriate DSB repair pathway, for genome stability maintenance: the trans-S double-strand break repair model. Cell Cycle, 7, 33-38.
20. Downs, J.A. and Jackson, S.P. (2004) A means to a DNA end: the many roles of Ku. Nat. Rev. Mol. Cell Biol., 5, 367-378.
21. Lieber, M.R., Ma, Y., Pannicke, U. and Schwarz, K. (2008) The mechanism of vertebrate nonhomologous DNA end joining and its role in V(D)J recombination. DNA Repair, 3, 817-826.
22. Van Gent, D.C. and Van Der Burg, M. (2007) Non-homologous end-joining, a sticky affair. Oncogene, 26, 7731-7740.
23. Soderberg, O., Leuchowius, K.J., Gullberg, M., Jarvius, M., Weibrecht, I., Larsson, L.G. and Landegren, U. (2008) Characterizing proteins and their interactions in cells and tissues using the in situ proximity ligation assay. Methods, 45, 227-232.
24. Rubin, E., Wu, X., Zhu, T., Cheung, J.C., Chen, H., Lorincz, A., Pandita, R.K., Sharma, G.G., Ha, H.C., Gasson, J. et al. (2007) A role for the HOXB7 homeodomain protein in DNA repair. Cancer Res., 67, 1527-1535.
25. Schild-Poulter, C., Pope, L., Giffin, W., Kochan, J.C., Ngsee, J.K., Traykova-Andonova, M. and Haché, R.J.G. (2001) The binding of Ku antigen to homeodomain proteins promotes their phosphorylation by DNA-dependent protein kinase. J. Biol. Chem., 276, 16848-16856.
26. Modica, S., Morgano, A., Salvatore, L., Petruzzelli, M., Vanier, M.T., Valanzano, R., Esposito, D.L., Palasciano, G., Duluc, I., Freund, J.N. et al. (2009) Expression and localisation of insulin receptor substrate 2 in normal intestine and colorectal tumours. Regulation by intestine-specific transcription factor CDX2. Gut, 58, 1250-1259.
27. Brenkman, A.B., van den Broek, N.J.F., de Keizer, P.L.J., van gent, D.C. and Burgering, B.M.T. (2010) The DNA damage repair protein Ku70 interacts with FOXO4 to coordinate a conserved cellular stress response. FASEB J., 24, 4271-4280.
28. Fattah, F., Lee, E.H., Weisensel, N., Wang, Y., Lichter, N. and Hendrickson, E.A. (2010) Ku regulates the non-homologous end joining pathway choice of DNA double-strand break repair in human somatic cells. Plos Genet., 6, E1000855.
29. Wang, M., Wu, W., Wu, W., Rosidi, B., Zhang, L., Wang, H. and Iliakis, G. (2006) PARP-1 And Ku compete for repair of DNA double strand breaks by distinct NHEJ pathways. Nucleic Acids Res., 34, 6170-6182.
30. Iliakis, G., Rosidi, B., Wang, M. and Wang, H. (2006) Plasmid-based assays for DNA end-joining in vitro. Methods Mol. Biol., 314, 123-131.
31. Lieber, M.R. (2008) The mechanism of human nonhomologous DNA end joining. J. Biol. Chem., 283, 1-5.
32. Lieber, M.R., Lu, H., Gu, J. and Schwarz, K. (2008) Flexibility in the order of action and in the enzymology of the nuclease, polymerases, and ligase of vertebrate non-homologous DNA end joining: relevance to cancer, aging, and the immune system. Cell Res., 18, 125-133.
33. Collis, S.J., Deweese, T.L., Jeggo, P.A. and Parker, A.R. (2004) The life and death of DNA-PK. Oncogene, 24, 949-961.
34. Roos, W.P. and Kaina, B. (2006) DNA damage-induced cell death by apoptosis. Trends Mol. Med., 12, 440-450.
35. Rings, E.H., Boudreau, F., Taylor, J.K., Moffett, J., Suh, E.R. and Traber, P.G. (2001) Phosphorylation of the Serine 60 residue within the Cdx2 activation domain mediates its transactivation capacity. Gastroenterology, 121, 1437-1450.
36. Verzi, M.P., Hatzis, P., Sulahian, R., Philips, J., Schuijers, J., Shin, H., Freed, E., Lynch, J.P., Dang, D.T., Brown, M. et al. (2010) TCF4 and CDX2, major transcription factors for intestinal function, converge on the same Cis-regulatory regions. Proc. Natl Acad. Sci. USA, 107, 15157-15162.
37. Schild-Poulter, C., Shih, A., Tantin, D., Yarymowich, N.C., Soubeyrand, S., Sharp, P.A. and Hache, R.J.G. (2007) DNA-PK phosphorylation sites on Oct-1 promote cell survival following DNA damage. Oncogene, 26, 3980-3988.
38. Gaymes, T.J., North, P.S., Brady, N., Hickson, I.D., Mufti, G.J. and Rassool, F.V. (2002) Increased error-prone non homologous DNA end-joining-a proposed mechanism of chromosomal instability in Bloom's syndrome. Oncogene, 21, 2525-2533.
39. Mallo, G.V., Soubeyran, P., Lissitzky, J.C., Andre, F., Farnarier, C., Marvaldi, J., Dagorn, J.C. and Iovanna, J.L. (1998) Expression of the Cdx1 and Cdx2 homeotic genes leads to reduced malignancy in colon cancer-derived cells. J. Biol. Chem., 273, 14030-14036.
40. Brattain, M.G., Fine, W.D., Khaled, F.M., Thompson, J. and Brattain, D.E. (1981) Heterogeneity of malignant cells from a human colonic carcinoma. Cancer Res., 41, 1751-1756.
41. Leibovitz, A., Stinson, J.C., Mccombs, W.B., Mccoy, C.E., Mazur, K.C. and Mabry, N.D. (1976) Classification of human colorectal adenocarcinoma cell lines. Cancer Res., 36, 4562-4569.
42. Lozzio, C.B. and Lozzio, B.B. (1975) Human chronic myelogenous leukemia cell-line with positive philadelphia chromosome. Blood, 45, 321-334.
43. Han, T., Dadey, B. and Minowada, J. (1978) Unique leukemic non-T/Non-B lymphoid cell lines (REH And KM-3): absence of MLR-S and presence of suppressor cell activity for normal T-cell response. J. Clin. Lab. Immunol., 1, 237-243.
44. Delalande, F., Carapito, C., Brizard, J.P., Brugidou, C. and Van Dorsselaer, A. (2005) Multigenic families and proteomics: extended protein characterization as a tool for paralog gene identification. Proteomics, 5, 450-460.
45. Pastwa, E., Neumann, R.D. and Winters, T.A. (2001) In vitro repair of complex unligatable oxidatively induced DNA double-strand breaks by human cell extracts. Nucleic Acids Res., 29, E78.